Litigation Details for Alkermes Pharma Ireland Limited v. Luye Pharma Group LTD. (S.D. Cal. 2019)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2019-11-21
Court	District Court, S.D. California	Date Terminated	2019-11-24
Cause	35:0271 Patent Infringement	Assigned To	Cynthia Ann Bashant
Jury Demand	None	Referred To	Bernard G. Skomal
Patents	6,667,061
Link to Docket	External link to docket

The small molecule drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2019-11-21	1	Motion to Quash	Defendants’) for patent infringement of 25 26 U.S. Patent No. 6,667,061 (“the ’061 Patent”) for a “Preparation…Risperi- 4 done Product) that infringes the ‘061 Patent. 5 Ajinomoto has no interest in this… a 9 diluent. With respect to the claim of patent infringement, Defendants’ Risperidone Product will…show whether or not 11 it infringes the ‘061 Patent. The diluent used is not a component that is alleged…alleged to have infringed any 12 13 patents. Plaintiffs should be able to obtain Defendants’ Risperidone	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document